glp-1 obesity drug news updates The next phase of the race New Guidelines on GLP-1 Drugs

Serious adverse events reported in temporal association with GLP-1 RA exposure included anaphylaxis with bronchospasm (n=4 cases), acute eosinophilic pneumonia (n=1), perioperative aspiration pneumonitis or pneumonia (multiple perioperative cases across two cohort studies and one case series), acute respiratory distress syndrome (ARDS

Adolescents with obesity prescribed a GLP-1 receptor agonist are less likely to have suicidal ideation or a suicide attempt than those with obesity treated with lifestyle intervention, according to new data

This interaction triggers multiple beneficial effects, such as enhancing insulin release from the pancreas when glucose levels are high, suppressing glucagon (which raises blood sugar), and signaling the brain to promote fullness

This circadian rhythm is regulated by food intake..

GLP-1 agonists are powerful weight loss tools, but certain medications can reduce their effectiveness or cause harmful interactions

CBS News medical correspondent Dr